Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Why Clearwater CWAN valuation makes sense when you dig deeper Smart Money Flows 20260506 TPET Trio Petroleum management lays out new upstream project plans to drive longterm revenue and margin expansion What you need to know before buying iRhythm Holdings IRTC Bullish Sentiment 20260508 The quiet positioning of Star Bulk SBLK nobody discusses Flirts with Breakout 20260503 UK Government Unveils VAT Reduction on Theme Park Tickets and Childrens Meals to Ease CostofLiving Burden Silicon Valley Praises Chinese AI Model DeepSeek Despite Chip Constraints New IRDAI Regulations Pose Challenges for Insurance CEOs Raise Competitiveness Concerns Healthcare and Tech Lift SP 500 to New High Communication Services Lags Trump Seeks Independence in Next Fed Chair Amid History of Rate Cut Pressure VanEck Tokenized Fund Integrates with Euler Protocol Expanding Institutional DeFi Access MDU Q1 2026 Earnings EPS Misses Estimates by 72 Stock Gains 15 AGNCO Q1 2026 Earnings Preferred Dividend Surpasses Expectations as FixedtoFloating Rate Benefits PED Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction NTR Q1 2026 Earnings EPS Miss Slightly but Stock Gains Amid Mixed Sentiment Kirby KEX Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline CAE Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises GAMCO Global Gold Natural Resources Income Trust GGN Slips 077 Amid Sector Uncertainty Limbach Holdings LMB Edges Lower Holds Above Key Support Amid Sector Rotation Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181 Embraer EMBJ Gains 188 as Aerospace Demand Provides Tailwind Old Republic International ORI Edges Lower Remains Within Established Range Spotify Shares Surge 13 on 2030 Revenue Guidance and AI Licensing Deal with Universal Music Group Byju Raveendran Sentenced to Jail by Singapore Court for Contempt Eli Lillys NextGeneration Obesity Drug Retatrutide Achieves Primary Endpoint in Pivotal Trial Medantas Growth Strategy Established Units and Expansion Plans Under Review Veteran Trader Steve Burns Issues Bear Market Warning Highlights Three Investor Pitfalls Mizuho Maintains Outperform Rating on ON Semiconductor Signals Continued Confidence